Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis

Background Severe acute respiratory syndrome coronavirus 2 is the virus that causes coronavirus disease 2019. Over six million deaths worldwide have been associated with coronavirus disease 2019. Objective To assess the cost-effectiveness of treatments used for the treatment of coronavirus disease 2...

Full description

Bibliographic Details
Main Authors: Metry Andrew, Pandor Abdullah, Ren Shijie, Shippam Andrea, Clowes Mark, Dark Paul, McMullan Ronan, Stevenson Matt
Format: Article
Language:English
Published: NIHR Journals Library 2023-08-01
Series:Health Technology Assessment
Subjects:
Online Access:https://doi.org/10.3310/NAFW3527